Search for: "IN RE WYETH"
Results 181 - 200
of 702
Sort by Relevance
|
Sort by Date
23 Aug 2012, 12:47 pm
At least they’re paying attention. [read post]
22 Aug 2012, 5:00 am
Wyeth-Ayerst Labs., 585 F.3d 361 (6th Cir. 2004), and the bad one (wretched, awful, horrible, etc - we're tempted to unload the thesaurus on this one) is Desiano v. [read post]
16 Aug 2012, 11:25 pm
New Jersey’s high court said that the Gannons’ suit had to be dismissed to avoid re-litigating the case. [read post]
14 Aug 2012, 8:50 pm
The FTC hoped to assist the court in its analysis of the economic realities of the challenged agreement, it said.The plaintiffs in the Effexor action allege that in 2005, Wyeth and Teva entered into a so-called “No-AG” agreement, whereby Wyeth agreed to refrain from marketing an authorized generic (“AG”) version of Effexor XR during Teva’s 180 exclusivity period under the Hatch-Waxman Act, in exchange for Teva’s agreement to delay introduction of… [read post]
14 Aug 2012, 8:50 pm
The FTC hoped to assist the court in its analysis of the economic realities of the challenged agreement, it said.The plaintiffs in the Effexor action allege that in 2005, Wyeth and Teva entered into a so-called “No-AG” agreement, whereby Wyeth agreed to refrain from marketing an authorized generic (“AG”) version of Effexor XR during Teva’s 180 exclusivity period under the Hatch-Waxman Act, in exchange for Teva’s agreement to delay introduction of… [read post]
14 Aug 2012, 8:50 pm
The FTC hoped to assist the court in its analysis of the economic realities of the challenged agreement, it said.The plaintiffs in the Effexor action allege that in 2005, Wyeth and Teva entered into a so-called “No-AG” agreement, whereby Wyeth agreed to refrain from marketing an authorized generic (“AG”) version of Effexor XR during Teva’s 180 exclusivity period under the Hatch-Waxman Act, in exchange for Teva’s agreement to delay introduction of… [read post]
13 Aug 2012, 7:02 pm
SSRIs, selective serotonin re-uptake inhibitors, is a class of anti-depressants that are Food and Drug Administration-approved to treat depression, anxiety disorders, panic conditions, obsessive-compulsive disorder, and premenstrual dysphoric disorder. [read post]
10 Aug 2012, 7:48 am
Wyeth Pharmaceuticals, Inc., No. 11-2058-STA-cgc, slip op. [read post]
9 Aug 2012, 5:00 am
Wyeth (hormone therapy) Deposition2007-12-20 In re Prempro PLL (hormone therapy) Deposition2008-02-01 Rix v. [read post]
7 Aug 2012, 4:10 am
Wyeth. [read post]
3 Aug 2012, 1:00 pm
Wyeth, Inc., 85 Cal. [read post]
24 Jul 2012, 12:24 pm
Wyeth, 2012 U.S. [read post]
19 Jul 2012, 4:30 am
Wyeth, et al., No. [read post]
8 Jul 2012, 10:58 am
In re Viagra Prods., 572 F. [read post]
27 Jun 2012, 5:00 am
In re Vioxx, 2012 U.S. [read post]
25 Jun 2012, 1:57 pm
Wyeth, Inc. [read post]
22 Jun 2012, 2:23 pm
Wyeth, Inc., 657 F.3d 420 (6th Cir. 2011) — is no more availing now. [read post]
21 Jun 2012, 7:40 am
Wyeth, Inc., 63 D. [read post]
21 Jun 2012, 4:30 am
Wyeth Labs., 498 F.2d 1264, 1276 (5th Cir. 1974). [read post]
20 Jun 2012, 5:00 am
Now where were we? [read post]
